A new bioprocessing technique developed by a team of researchers could improve a range of therapies based on CAR-T cells.

The cell-based platform uses an often-undervalued subset of helper T cells to deliver antitumor proteins for solid tumors, overcoming dose-related toxicities. Kelly Brieger SRI +1 650-704-1748 email ...

Researchers discover a novel protein therapy that recharges exhausted T cells, unleashing their power to eradicate tumors and ...

During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

"Hot tumors tend to have a greater number of lymphocytes, in particular T cells, certainly CD8 but probably also CD4, cells that are specific for ... impact on cancer immunotherapy in the near future.

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

An arist's illustration of DeltaRex-G mechanism of action in CAR-T induced CRS. By killing a certain proportion ... supported by the inhibitory activity of DeltaRex-G in transduced CD4+ CD8+ cell ...